FRESENIUS SE+CO. ADR 1/4 (FREA F) stock market data APIs
€11.5703
0(0%)
as of December 19, 2025
Try our APIs with
free plan!
FRESENIUS SE+CO. ADR 1/4 Financial Data Overview
Price chart is built with
Anychart
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Prev. Close
11.5703
Open
11.5703
High
11.5703
Low
11.5703
52 wk Range
7.9111-20
Market Cap
26 401 M
P/E Ratio
22.7451
Shares Outstanding
2 253 M
Revenue
22 445 M
EPS
0.0359
Dividends (Yield)
0.087
Beta
0.921
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get FRESENIUS SE+CO. ADR 1/4 data using free add-ons & libraries
Get FRESENIUS SE+CO. ADR 1/4 Fundamental Data
FRESENIUS SE+CO. ADR 1/4 Fundamental data includes:
- Net Revenue: 22 445 M
- EBITDA: 2 515 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
FRESENIUS SE+CO. ADR 1/4 News
New
Here's What's Concerning About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop up? Businesses in decline often have two underlying trends, firstly, a declining re...
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature
Rocuronium Bromide Injection Room Temperature Stable, now available from Fresenius Kabi. New product requires no refrigeration LAKE ZURICH, Ill., December 18, 2025--(BUSINESS WIRE)--Fresenius Kabi, ...
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
MADRID, Dec. 4, 2025 /PRNewswire/ -- mAbxience, a Fresenius entity, and HP Inc., a global leader in technology, announce a new project to develop an innovative artificial intelligence (AI) solution t...
North America Heart Pump Device Market Forecast and Company Analysis Report 2025-2033 Featuring Abbott, Getinge, Teleflex, Fresenius, LivaNova, CorWave, JARVIK HEART, ABIOMED
Company Logo The North America Heart Pump Device market is projected to grow from USD 2.92 billion in 2024 to USD 8.1 billion by 2033, reflecting a CAGR of 12% between 2025-2033. Key drivers include ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
